Longeveron Inc. (LGVN)
$2.48+4.64%Close
SELLCRISIS · day 17
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $49M
- Beta
- -0.26
- P/E (TTM)
- -0.23
- Short % float
- 0.66%
- Days to cover
- 1.0
- SI change
- -50.0%
- 1W
- -3.88%
- 1M
- -62.65%
- vs SPY 1W
- -5.04%
- vs SPY 1M
- -65.64%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on LGVN?
- LOPJLB’s latest quantitative signal on Longeveron Inc. (LGVN) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is LGVN in?
- Longeveron Inc. (LGVN) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Longeveron Inc. (LGVN) do?
- Longeveron Inc. is a biotechnology company currently in the clinical development stage, dedicated to pioneering cell-based therapies. These treatments are designed to address both age-related conditions and various critical, life-threatening illnesses. The company's primary investigational product is LOMECEL-B, a sophisticated cellular therapy. This product is created from medicinal signaling c…